Short Interest in Integrated BioPharma Inc. (OTCMKTS:INBP) Expands By ∞

Posted by on Sep 16th, 2026

Integrated BioPharma Inc. (OTCMKTS:INBP – Get Free Report) saw a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 4 shares, a growth of ∞ from the August 15th total of 0 shares. Based on an average trading volume of 12,617 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

Integrated BioPharma Stock Up 2.4%

INBP traded up $0.00 during midday trading on Wednesday, hitting $0.17. The company had a trading volume of 3,000 shares, compared to its average volume of 10,423. The stock’s 50 day moving average price is $0.17 and its 200 day moving average price is $0.21. Integrated BioPharma has a 52 week low of $0.14 and a 52 week high of $0.42. The company has a market capitalization of $5.39 million, a price-to-earnings ratio of -2.49 and a beta of 0.40.

About Integrated BioPharma

(Get Free Report)

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.

Featured Stories

Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.